Protein subunit vaccines: Promising frontiers against COVID-19

VP Chavda, ENHK Ghali, PC Balar… - Journal of Controlled …, 2024 - Elsevier
The emergence of COVID-19 has posed an unprecedented global health crisis, challenging
the healthcare systems worldwide. Amidst the rapid development of several vaccine …

Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines

PD Trivedi, BJ Byrne, M Corti - Viruses, 2023 - mdpi.com
Efficient and targeted delivery of a DNA payload is vital for develo** safe gene therapy.
Owing to the recent success of commercial oncolytic vector and multiple COVID-19 …

[HTML][HTML] SARS-CoV-2 vaccines: the advantage of mucosal vaccine delivery and local immunity

J Tobias, P Steinberger, J Wilkinson, G Klais, M Kundi… - Vaccines, 2024 - mdpi.com
Immunity against respiratory pathogens is often short-term, and, consequently, there is an
unmet need for the effective prevention of such infections. One such infectious disease is …

Hypocortisolemic ASIA: a vaccine-and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis

M Ruiz-Pablos, B Paiva, A Zabaleta - Frontiers in Immunology, 2024 - frontiersin.org
Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), long COVID (LC) and
post-COVID-19 vaccine syndrome show similarities in their pathophysiology and clinical …

Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines

AG Francisco, JCB Reyes, IKB Tabios, CJG Cruz… - Plos one, 2023 - journals.plos.org
Human adenovirus (HAdV), particularly the HAdV type 5 (HAdV-5), has been extensively
utilized in the development of vector vaccines due to its high immunogenicity, good safety …

Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of …

P Mohite, V Yadav, R Pandhare, S Maitra, FM Saleh… - ACS …, 2024 - ACS Publications
In the realm of cancer immunotherapy, a profound evolution has ushered in sophisticated
strategies that encompass both traditional cancer vaccines and emerging viral vaccines …

Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines

C Zhu, S Pang, J Liu, Q Duan - Drugs, 2024 - Springer
The COVID-19 pandemic has resulted in over 772 million confirmed cases, including nearly
7 million deaths, according to the World Health Organization (WHO). Leveraging rapid …

Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus

N Chowdhury, A Kundu - Diseases, 2023 - mdpi.com
The COVID-19 pandemic has had a profound impact on societies, public health, healthcare
systems, and the world economy. With over 771 million people infected worldwide and a …

Caveats of chimpanzee ChAdOx1 adenovirus-vectored vaccines to boost anti-SARS-CoV-2 protective immunity in mice

J Cervantes-Torres, C Cabello-Gutiérrez… - Applied Microbiology …, 2024 - Springer
Several COVID-19 vaccines use adenovirus vectors to deliver the SARS-CoV-2 spike (S)
protein. Immunization with these vaccines promotes immunity against the S protein, but …

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics

VP Chavda, N Raval, S Sheta, LK Vora… - Frontiers in …, 2023 - frontiersin.org
The newly emerged coronavirus (SARS-CoV-2) is virulent, contagious, and has rapidly
gained many mutations, which makes it highly infectious and swiftly transmissible around …